Patents Assigned to MDXHEALTH SA
  • Patent number: 8481700
    Abstract: An oligonucleotide, primer or probe comprises the nucleotide sequences of any of SEQ ID NO. 5, 6, 7, 2, 3, 4, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 25. The oligonucleotides are useful for the detection of the methylation status of a gene, in particular the MAGE-A3 gene. The oligonucleotides are useful in primer pairs, kits and methods for determining the methylation status of the MAGE-A3 gene and for diagnosing cancer, directing therapy and selecting subjects for treatment. The primer or probe can comprise a loop or hairpin structure and can be used in real-time methylation specific PCR.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: July 9, 2013
    Assignees: MDxHealth SA, GlaxoSmithKline Biologicals SA
    Inventors: Ilse Vlassenbroeck, Katja Bierau
  • Publication number: 20120039993
    Abstract: An oligonucleotide, primer or probe comprises the nucleotide sequence of any of SEQ ID NO. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 44, 61, 62 or 63. The oligonucleotide, primer or probe is useful for the detection of the methylation status of a gene. The oligonucleotides find application in the diagnosis and treatment of cancer.
    Type: Application
    Filed: March 17, 2010
    Publication date: February 16, 2012
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, MDXHEALTH SA
    Inventors: Gaetan Otto, Catherine Bovie